Source: International Congress 2016 – What's new in biomarker analysis?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Giuseppe Valerio (Brindisi, Italy), Giuseppe Valerio, Pierluigi Bracciale, Donato Lacedonia. Determinants of oxidants load in broncho-alveiolar milieu. Eur Respir J 2016; 48: Suppl. 60, 911

Member's Comments

No comment yet.

Related content which might interest you: Assessment of ATP degradation in bronchoalveolar lavage fluid Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis Source: International Congress 2015 – IPF pathogenesis Year: 2015 Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid Source: International Congress 2014 – Translational studies in COPD Year: 2014 Oxidative imbalance in biological fluids of heavy metals-exposed workers Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis Source: International Congress 2014 – ILDs 5 Year: 2014 Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Characterization of inflammation in bronchoalveolar lavage of lung transplant patients Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Electronic nose breathprints reflect BALF inflammatory cell counts in asthma Source: Annual Congress 2013 –Asthma Year: 2013 Characteristics of endobronchial dendritic cells in patients with stable COPD Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Periostin in lower airway samples and serum, a novel asthma marker? Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 LATE-BREAKING ABSTRACT: Molecular diagnostics in the bronchoalveolar lavage in a large cohort of immunocompromised patients Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Bronchoalveolar lavage: did it fulfill its promises? Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice Year: 2005